DK2262525T3 - Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme - Google Patents

Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme

Info

Publication number
DK2262525T3
DK2262525T3 DK09720761.7T DK09720761T DK2262525T3 DK 2262525 T3 DK2262525 T3 DK 2262525T3 DK 09720761 T DK09720761 T DK 09720761T DK 2262525 T3 DK2262525 T3 DK 2262525T3
Authority
DK
Denmark
Prior art keywords
apoaequorin
methods
same
containing compositions
compositions
Prior art date
Application number
DK09720761.7T
Other languages
English (en)
Inventor
Mark Y Underwood
Original Assignee
Quincy Bioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quincy Bioscience Llc filed Critical Quincy Bioscience Llc
Application granted granted Critical
Publication of DK2262525T3 publication Critical patent/DK2262525T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK09720761.7T 2008-03-11 2009-03-11 Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme DK2262525T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3544308P 2008-03-11 2008-03-11
PCT/US2009/036767 WO2009114597A1 (en) 2008-03-11 2009-03-11 Apoaequorin-containing compositions and methods of using same

Publications (1)

Publication Number Publication Date
DK2262525T3 true DK2262525T3 (da) 2013-02-11

Family

ID=40627496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09720761.7T DK2262525T3 (da) 2008-03-11 2009-03-11 Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme

Country Status (19)

Country Link
US (1) US8796213B2 (da)
EP (1) EP2262525B1 (da)
JP (1) JP5508294B2 (da)
KR (1) KR101643662B1 (da)
CN (2) CN101969979A (da)
AU (1) AU2009223010B2 (da)
BR (1) BRPI0909435A2 (da)
CA (1) CA2717322C (da)
CY (1) CY1114366T1 (da)
DK (1) DK2262525T3 (da)
ES (1) ES2401754T3 (da)
HR (1) HRP20130205T1 (da)
IL (1) IL207827A (da)
MX (1) MX2010009753A (da)
NZ (1) NZ588437A (da)
PL (1) PL2262525T3 (da)
PT (1) PT2262525E (da)
SI (1) SI2262525T1 (da)
WO (1) WO2009114597A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201402364WA (en) * 2011-11-15 2014-09-26 Quincy Bioscience Llc Apoaequorin for reducing neuronal injury due to ischemia
TR201818988T4 (tr) * 2012-09-27 2019-01-21 Quincy Bioscience Llc Multipl skleroz semptomlarını hafifletmeye yönelik apoaequorin içeren bileşimlere dayalı yöntemler.
MA40959A (fr) * 2014-11-11 2017-09-19 Quincy Bioscience Llc Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale
HUE067969T2 (hu) * 2016-09-23 2024-12-28 Quincy Bioscience Llc Apoaequorint és D-vitamint tartalmazó készítmények és alkalmazási eljárásaik
BR112021016587A2 (pt) 2019-02-22 2021-11-03 Aquero Canada Ltd Composições de leite fortificadas e seus processos de preparação
AU2020310953B2 (en) 2019-07-09 2026-07-02 Aquero Canada Ltd. Compositions, processes of production, sterilization, and health-promoting uses of lyophilized milk
EP4110312A1 (en) * 2020-02-24 2023-01-04 Quincy Bioscience, LLC Apoaequorin and curcumin containing compositions and methods
MX2023001830A (es) * 2020-08-20 2023-03-13 Quincy Bioscience Llc Formulacion efervescente que contiene apoaecuorina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6447379A (en) * 1987-08-19 1989-02-21 Chisso Corp Preparation of calcium-dependent oxygenation enzyme
US20060229243A1 (en) 2004-06-21 2006-10-12 Quincy Resource Group, Inc. Aequorin-containing compositions and methods of using same
CN1324045C (zh) 2004-09-22 2007-07-04 中国科学院海洋研究所 从水母中分离的具有抗氧化活性的蛋白及其应用

Also Published As

Publication number Publication date
NZ588437A (en) 2012-07-27
KR101643662B1 (ko) 2016-07-29
JP2011513496A (ja) 2011-04-28
HRP20130205T1 (hr) 2013-04-30
EP2262525A1 (en) 2010-12-22
EP2262525B1 (en) 2012-12-26
JP5508294B2 (ja) 2014-05-28
IL207827A0 (en) 2010-12-30
CA2717322A1 (en) 2009-09-17
KR20100136494A (ko) 2010-12-28
MX2010009753A (es) 2010-09-30
IL207827A (en) 2013-08-29
AU2009223010A1 (en) 2009-09-17
AU2009223010B2 (en) 2014-01-09
US8796213B2 (en) 2014-08-05
US20110124562A1 (en) 2011-05-26
PL2262525T3 (pl) 2013-04-30
CN101969979A (zh) 2011-02-09
CA2717322C (en) 2017-07-11
PT2262525E (pt) 2013-01-28
WO2009114597A1 (en) 2009-09-17
BRPI0909435A2 (pt) 2017-06-13
CY1114366T1 (el) 2016-08-31
ES2401754T3 (es) 2013-04-24
SI2262525T1 (sl) 2013-03-29
CN106692945A (zh) 2017-05-24

Similar Documents

Publication Publication Date Title
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2203478T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antistoffer mod sclerostin
DK3156069T3 (da) Sammensætninger, fremgangsmåder, og kits til fremkaldelse af et immunrespons
DK2001611T3 (da) Fremgangsmåde og sammensætning til oprensning af jord
DK2068927T3 (da) Fremgangsmåder til reducering af eosinofilniveauer
BRPI0920284A2 (pt) composição e método
DK3121280T3 (da) Antisense-sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
HRP20150031T1 (xx) Derivati piridazinona
PL2356462T3 (pl) Kompozycje anty-CXCR1 oraz sposoby
BRPI0813775A2 (pt) Composição
BRPI0809573A2 (pt) composição, e, método
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
BRPI0814167A2 (pt) Composição, e, método
DK3263112T3 (da) Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
PT2182988E (pt) Composição radiofarmacêutica
BRPI0809678A2 (pt) Métodos
DK1912476T3 (da) Fremgangsmåde til træning af høreevne
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
DK2187967T3 (da) Fremgangsmåde og sammensætninger til behandling af cancere